There is a generic Nipent (pentostatin) product available at this time. It comes in one form and strength. The U.S. Food and Drug Administration has tested this generic product and has determined it is as good as the brand-name drug; however, generic medications may contain different inactive ingredients than the brand-name product.
Nipent® (pentostatin) is a prescription medication used to treat hairy cell leukemia, a rare type of blood cancer. It belongs to a group of medicines known as purine analogs.
Brand-name Nipent is made by Hospira, Inc. It is no longer protected from generic competition by patents, and is available as a generic medication.
Generic Nipent is available in one strength and form: Pentostatin 10 mg per vial.
Generic Nipent is made by Bedford Laboratories.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AP" rating means that the FDA has determined that a generic injectable medication is equivalent to a brand-name injectable medication. All of the generic Nipent versions currently available have an "AP" rating, meaning they should be equivalent to Nipent.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.